“This is the fourth COVID-19 vaccine approved by an independent UK regulator and the first licensed single-component COVID-19 vaccine,” the statement said.
In March, the World Health Organization (WHO) added the Johnson & Johnson coronavirus vaccine to the list of recommended for emergency use.
The Janssen vaccine was overall 66% effective in preventing mild COVID-19 28 days after vaccination and 85% effective in preventing severe coronavirus.